Identification of M2 Macrophage-Related Key Genes in Advanced Atherosclerotic Plaques by Network-Based Analysis
Authors:
- 1 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 83 (3) , 276-288
Abstract
Atherosclerotic plaque accounts for major adverse cardiovascular events because of its vulnerability. The classically activated macrophage (M1) and alternatively activated macrophage (M2) are implicated in the progression and regression of plaque, respectively. However, the therapeutic targets related to M2 macrophages still remain largely elusive. In this study, cell-type identification by estimating relative subsets of RNA transcripts and weighted gene coexpression network analysis algorithms were used to establish a weighted gene coexpression network for identifying M2 macrophage-related hub genes using GSE43292 data set. The results showed that genes were classified into 7 modules, with the blue module (Cor = 0.67, P = 3e−05) being the one that was most related to M2 macrophage infiltration in advanced plaques, and then 99 hub genes were identified from blue module. Meanwhile, 1289 differentially expressed genes were produced in GSE43292 data set. Subsequently, the intersection genes of hub genes and differentially expressed genes, including AKTIP, ASPN, FAM26E, RAB23, PLS3, and PLSCR4, were obtained by Venn diagrams and named as key genes. Further validation using data sets GSE100927 and GSE41571 showed that 6 key genes all downregulated in advanced and vulnerable plaques compared with early and stable plaque samples (|Log2 (fold change)| > 0.5, P < 0.05 or 0.001), respectively. Receiver operator characteristic curve analysis indicated that the 6 key genes might have potential diagnostic value. The validation of key genes in the model in vitro and in vivo also demonstrated decreased mRNA expressions of AKTIP, ASPN, FAM26E, RAB23, PLS3, and PLSCR4 (P < 0.05 or 0.001). Collectively, we identified AKTIP, ASPN, FAM26E, RAB23, PLS3, and PLSCR4 as M2 macrophage-related key genes during atherosclerotic progression, proposing potential intervention targets for advanced atherosclerotic plaques.Keywords
This publication has 37 references indexed in Scilit:
- Human CALHM5: Insight in large pore lipid gating ATP channel and associated neurological pathologiesMolecular and Cellular Biochemistry, 2021
- Genome-Wide Assessment for Resting Heart Rate and Shared Genetics With Cardiometabolic Traits and Type 2 DiabetesJACC, 2019
- Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseJAMA Cardiology, 2019
- Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular DiseaseThe American Journal of Cardiology, 2019
- Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapyHeart Failure Reviews, 2019
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- Macrophages in atherosclerosis: a dynamic balanceNature Reviews Immunology, 2013
- Identification of two genes potentially associated in iron-heme homeostasis in human carotid plaque using microarray analysisJournal of Biosciences, 2013
- Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque ruptureAtherosclerosis, 2013
- Lipid metabolic effect of Korean red ginseng extract in mice fed on a high‐fat dietJournal of the Science of Food and Agriculture, 2011